In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Leadership

Set Alert for Leadership

Personalized Medicine: A Patient Primer On Best Practice

Personalized medicine is focused on meeting patients’ needs, but it also has the potential to transform the delivery and financing of health care. In Vivo probes the path toward meeting both goals in an in-depth nterview with Eleanor Perfetto, SVP for strategic initiatives at the National Health Council, the DC-based patient advocacy organization whose members include groups representing 133 million patients nationwide.

Personalized Medicine Leadership Pricing Debate
Advertisement

Latest From Leadership

Execs On The Move, March 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Leadership BioPharmaceutical

The Frost Factor: An M&A Leader's Standout Strategy For Opko Health

With CEO leadership in the biopharma industry more short-cycled than ever, billionaire entrepreneur Phillip Frost ranks as a competitor for the long game – the last man standing in an endurance test spanning four decades of exposure to every iteration of a fast-changing business model.

Business Strategies Deals

Execs On The Move, February 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Leadership BioPharmaceutical

Pharma's Reputation In A Post-Fact World

How should an industry built on expertise, evidence and facts adapt to a new, break-the-wheel era that’s had enough of the experts? Four points to act on before the Tweetstorm visits the C-suite.

Business Strategies Leadership

Life Science’s Tangled Bank Of Business Models

The pharma industry is experiencing an explosion of new business models, more numerous and specialized than we're used to. Companies need to pick the right model and adapt faster and better than their competitors. Part 3 in a series from Brian Smith's new book, Darwin's Medicine.

Business Strategies Leadership

Execs On The Move, January 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

BioPharmaceutical Medical Device
See All
UsernamePublicRestriction

Register